speb/financial-data huggingface dataset:
DuPont ROE decomposition for CPA.DE (annual period ending 2023-12-31)
ROE: 278.50255246738516%
Net margin: 12.617566942488564%
Asset turnover: 1.211368447266841
Equity multiplier (leverage): 18.221213840045376
EBIT margin: 20.995014647684638%
Interest burden factor: 0.8303549571603427
Tax burden factor: 0.7237617924528302
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CPA.DE (annual period ending 2024-12-31)
ROE: 406.26249167221846%
Net margin: 15.168399582110343%
Asset turnover: 1.2393107062486513
Equity multiplier (leverage): 21.611592271818786
EBIT margin: 21.54121685488284%
Interest burden factor: 0.9136258660508083
Tax burden factor: 0.7707280080889788
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CPA.DE (annual period ending 2025-12-31)
ROE: 497.46974697469744%
Net margin: 11.093121381611226%
Asset turnover: 1.2590808005930318
Equity multiplier (leverage): 35.617161716171616
EBIT margin: 20.768324992640565%
Interest burden factor: 0.7226553271911174
Tax burden factor: 0.7391304347826086
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CPG.L (annual period ending 2022-09-30)
ROE: 18.925016694886967%
Net margin: 4.378331765432781%
Asset turnover: 1.3612916775520834
Equity multiplier (leverage): 3.175238962221211
EBIT margin: 6.204923173402401%
Interest burden factor: 0.9279848389131482
Tax burden factor: 0.7603812117077572
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CPG.L (annual period ending 2023-09-30)
ROE: 26.2004475097114%
Net margin: 4.252512728519799%
Asset turnover: 1.869608605516382
Equity multiplier (leverage): 3.295432258623773
EBIT margin: 6.774474371488116%
Interest burden factor: 0.8321651090342678
Tax burden factor: 0.7543284978942444
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CPG.L (annual period ending 2024-09-30)
ROE: 22.323622053308075%
Net margin: 3.36650635684015%
Asset turnover: 1.909264898722034
Equity multiplier (leverage): 3.4731139631418038
EBIT margin: 7.0187133946002564%
Interest burden factor: 0.6974219810040706
Tax burden factor: 0.6877431906614785
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CPG.L (annual period ending 2025-09-30)
ROE: 25.79951035822895%
Net margin: 4.080746689819839%
Asset turnover: 1.8159477023879695
Equity multiplier (leverage): 3.481516755043713
EBIT margin: 7.152159756891686%
Interest burden factor: 0.7842185128983309
Tax burden factor: 0.7275541795665635
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CPI.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 9.397036280020439
ROE archetype: Standard Business
DuPont ROE decomposition for CPI.L (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 10.144418245328824
ROE archetype: Standard Business
DuPont ROE decomposition for CPI.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 16.68438004212288
ROE archetype: Standard Business
DuPont ROE decomposition for CPPLUS.NS (annual period ending 2023-03-31)
ROE: 34.76029705321668%
Net margin: 4.743018442906513%
Asset turnover: 1.336399100635431
Equity multiplier (leverage): 5.483937431401118
EBIT margin: 6.830829379029843%
Interest burden factor: 0.9179039413288201
Tax burden factor: 0.7564568171976924
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CPPLUS.NS (annual period ending 2024-03-31)
ROE: 31.098195113951043%
Net margin: 4.140506587594443%
Asset turnover: 1.6460161537978832
Equity multiplier (leverage): 4.5629699753368005
EBIT margin: 7.499698014662108%
Interest burden factor: 0.789119461581604
Tax burden factor: 0.6996276250007594
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CPPLUS.NS (annual period ending 2025-03-31)
ROE: 48.37084504728434%
Net margin: 11.294780894385124%
Asset turnover: 1.2799135399916366
Equity multiplier (leverage): 3.3459945612871977
EBIT margin: 6.978598134235881%
Interest burden factor: 1.9994841015767146
Tax burden factor: 0.8094530526490388
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CPPLUS.NS (annual period ending 2026-03-31)
ROE: 24.53518814983311%
Net margin: 8.72828667870096%
Asset turnover: 1.1252661417718388
Equity multiplier (leverage): 2.4980730786643077
EBIT margin: 12.294359458504221%
Interest burden factor: 0.9507039400189466
Tax burden factor: 0.7467544196108754
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CPS.V (annual period ending 2022-09-30)
ROE: -112.67430844898081%
Asset turnover: 0
Equity multiplier (leverage): 1.8666808020941086
ROE archetype: Low Return
DuPont ROE decomposition for CPS.V (annual period ending 2023-09-30)
ROE: -906.0975668492732%
Asset turnover: 0
Equity multiplier (leverage): 5.764208394176598
ROE archetype: Low Return
DuPont ROE decomposition for CPS.V (annual period ending 2024-09-30)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CPS.V (annual period ending 2025-09-30)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CPX.L (annual period ending 2022-06-30)
ROE: -72.17444879019979%
Net margin: -88.87221400474334%
Asset turnover: 0.45697472218314
Equity multiplier (leverage): 1.777154963036399
EBIT margin: -87.23036172502276%
ROE archetype: Low Return
DuPont ROE decomposition for CPX.L (annual period ending 2023-06-30)
ROE: -81.39009186672193%
Net margin: -153.07272922523674%
Asset turnover: 0.28233410654359503
Equity multiplier (leverage): 1.8832603726592743
EBIT margin: -147.3504621815188%
ROE archetype: Low Return
DuPont ROE decomposition for CPX.L (annual period ending 2024-06-30)
ROE: -112.2702372804079%
Net margin: -133.74453846639483%
Asset turnover: 0.39616642329820606
Equity multiplier (leverage): 2.118902237474534
EBIT margin: -127.16263668800846%
ROE archetype: Low Return
DuPont ROE decomposition for CPX.L (annual period ending 2025-06-30)
ROE: -69.84995808145298%
Net margin: -79.47649738538183%
Asset turnover: 0.46009187609279084
Equity multiplier (leverage): 1.9102177041737536
EBIT margin: -84.02622250176984%
ROE archetype: Low Return
DuPont ROE decomposition for CQE.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.4873263040290483
ROE archetype: Standard Business
DuPont ROE decomposition for CRAMC.NS (quarterly period ending 2024-12-31)
Net margin: 49.85177052452193%
EBIT margin: 66.74003487507267%
Interest burden factor: 1.0036366303888071
Tax burden factor: 0.7442479623907328
ROE archetype: Standard Business
DuPont ROE decomposition for CRAMC.NS (quarterly period ending 2025-03-31)
ROE: 6.954123410251219%
Net margin: 41.21103066586737%
Asset turnover: 0.15022488653303834
Equity multiplier (leverage): 1.1232774301710426
EBIT margin: 58.304355598044154%
Interest burden factor: 0.987695768387746
Tax burden factor: 0.7156312274696366
ROE archetype: Standard Business
DuPont ROE decomposition for CRAMC.NS (quarterly period ending 2025-06-30)
Net margin: 62.83164138010626%
EBIT margin: 57.75495736113001%
Interest burden factor: 1.4251023197228179
Tax burden factor: 0.7633840656912467
ROE archetype: Standard Business
DuPont ROE decomposition for CRAMC.NS (quarterly period ending 2025-12-31)
Net margin: 48.05835104459229%
EBIT margin: 54.0213591861536%
Interest burden factor: 1.188661586224458
Tax burden factor: 0.7484195622442783
ROE archetype: Standard Business
DuPont ROE decomposition for CRAMC.NS (quarterly period ending 2026-03-31)
ROE: 5.545721535226292%
Net margin: 36.21706439097089%
Asset turnover: 0.13951031840249284
Equity multiplier (leverage): 1.097585809834926
EBIT margin: 60.46360938636946%
Interest burden factor: 0.8430106094265465
Tax burden factor: 0.7105360805615395
ROE archetype: Standard Business
DuPont ROE decomposition for CRAMC.NS (quarterly period ending 2026-06-30)
Net margin: 65.06238306939504%
EBIT margin: 60.52870275229042%
Interest burden factor: 1.4125274400300276
Tax burden factor: 0.7609773085966438
ROE archetype: Standard Business
DuPont ROE decomposition for CRBP2.PA (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 7.627283630996999
ROE archetype: Standard Business
DuPont ROE decomposition for CRBP2.PA (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 7.469944596825573
ROE archetype: Standard Business
DuPont ROE decomposition for CRBP2.PA (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 7.071824309175954
ROE archetype: Standard Business
DuPont ROE decomposition for CRD.A (annual period ending 2022-12-31)
ROE: -14.836518666212777%
Net margin: -1.4867294875189445%
Asset turnover: 1.5555465712874301
Equity multiplier (leverage): 6.415300945063139
EBIT margin: 4.110049657820741%
Interest burden factor: 0.09971543751482097
Tax burden factor: -3.6276258422512884
ROE archetype: Low Return
DuPont ROE decomposition for CRD.A (annual period ending 2023-12-31)
ROE: 23.25832323362803%
Net margin: 2.324288737576115%
Asset turnover: 1.655766684729925
Equity multiplier (leverage): 6.0435091505229686
EBIT margin: 5.510285750300512%
Interest burden factor: 0.6526059035912135
Tax burden factor: 0.6463458411639251
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CRD.A (annual period ending 2024-12-31)
ROE: 18.00786777799595%
Net margin: 1.983340417757295%
Asset turnover: 1.673123495745979
Equity multiplier (leverage): 5.426715236541157
EBIT margin: 5.062231071537767%
Interest burden factor: 0.6056302756212896
Tax burden factor: 0.6469157423623273
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CRD.A (annual period ending 2025-12-31)
ROE: 12.034876430884786%
Net margin: 1.501037131520788%
Asset turnover: 1.6719145693231423
Equity multiplier (leverage): 4.7955245379729226
EBIT margin: 5.563052942913139%
Interest burden factor: 0.47447958092208115
Tax burden factor: 0.5686705202312139
ROE archetype: Standard Business
DuPont ROE decomposition for CREG (quarterly period ending 2025-03-31)
ROE: -0.77383131815891%
Net margin: -4288.29090909091%
Asset turnover: 0.00015774652454769196
Equity multiplier (leverage): 1.1439374109873286
EBIT margin: -5635.830303030303%
ROE archetype: Low Return
DuPont ROE decomposition for CREG (quarterly period ending 2025-06-30)
ROE: -1.0873296730570277%
Net margin: -2000.8615424181055%
Asset turnover: 0.0004761248545287717
Equity multiplier (leverage): 1.1413618445701545
EBIT margin: -1648.0181309673064%
ROE archetype: Low Return
DuPont ROE decomposition for CREG (quarterly period ending 2025-09-30)
ROE: -0.25728253344207824%
Net margin: -330.73552081039423%
Asset turnover: 0.0006873548208144173
Equity multiplier (leverage): 1.1317447282065203
EBIT margin: -235.06936798062102%
ROE archetype: Low Return
DuPont ROE decomposition for CREG (quarterly period ending 2025-12-31)
ROE: -0.3627099248548471%
Net margin: -529.421496904896%
Asset turnover: 0.0006162115106420365
Equity multiplier (leverage): 1.1118035622194884
EBIT margin: -691.5329206527855%
ROE archetype: Low Return
DuPont ROE decomposition for CREG (quarterly period ending 2026-03-31)
ROE: -0.3788064273932756%
Net margin: -505.2098234474357%
Asset turnover: 0.0006873675950122568
Equity multiplier (leverage): 1.090828556490814
EBIT margin: -497.11313946083635%
ROE archetype: Low Return
DuPont ROE decomposition for CRISIL.NS (quarterly period ending 2024-12-31)
ROE: 8.760458823621152%
Net margin: 24.61250287542036%
Asset turnover: 0.23135249381014047
Equity multiplier (leverage): 1.5384978283076396
EBIT margin: 29.164977927725626%
Interest burden factor: 1.1060657276995305
Tax burden factor: 0.7629800672348808
ROE archetype: Standard Business
DuPont ROE decomposition for CRISIL.NS (quarterly period ending 2025-03-31)
Net margin: 19.656164686785214%
EBIT margin: 24.869032686490076%
Interest burden factor: 1.1238194135390398
Tax burden factor: 0.7033044396532758
ROE archetype: Standard Business
DuPont ROE decomposition for CRISIL.NS (quarterly period ending 2025-06-30)
ROE: 6.091473286562331%
Net margin: 20.351830324310217%
Asset turnover: 0.19925546875923275
Equity multiplier (leverage): 1.5021338086176044
EBIT margin: 24.56406728191502%
Interest burden factor: 1.086391732663705
Tax burden factor: 0.7626350180024002
ROE archetype: Standard Business
DuPont ROE decomposition for CRISIL.NS (quarterly period ending 2025-12-31)
ROE: 8.060683855117388%
Net margin: 22.32865186719306%
Asset turnover: 0.23833195831984447
Equity multiplier (leverage): 1.514701669675551
EBIT margin: 28.15074382610464%
Interest burden factor: 1.072420928170263
Tax burden factor: 0.7396177875780964
ROE archetype: Standard Business
DuPont ROE decomposition for CRISIL.NS (quarterly period ending 2026-03-31)
Net margin: 22.054346387307827%
EBIT margin: 26.393169827732915%
Interest burden factor: 1.1047107289987463
Tax burden factor: 0.7564044360853491
ROE archetype: Standard Business
DuPont ROE decomposition for CRISIL.NS (quarterly period ending 2026-06-30)
ROE: 6.616819915875966%
Net margin: 20.128511516752063%
Asset turnover: 0.21406461809792443
Equity multiplier (leverage): 1.5356518389905116
EBIT margin: 24.679418629520452%
Interest burden factor: 1.0544084400904297
Tax burden factor: 0.7735134362492854
ROE archetype: Standard Business
DuPont ROE decomposition for CRK (annual period ending 2022-12-31)
ROE: 50.075713883160965%
Net margin: 31.446088085165147%
Asset turnover: 0.6371434015512126
Equity multiplier (leverage): 2.4993284507754416
EBIT margin: 62.87500444452775%
Interest burden factor: 0.6145797212886007
Tax burden factor: 0.8137862951632128
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CRK (annual period ending 2023-12-31)
ROE: 9.091226974979111%
Net margin: 13.538609770948861%
Asset turnover: 0.2619894511812056
Equity multiplier (leverage): 2.5630945370647464
EBIT margin: 14.470046495164235%
Interest burden factor: 1.0905939807128475
Tax burden factor: 0.857908651802307
ROE archetype: Standard Business
DuPont ROE decomposition for CRK (annual period ending 2024-12-31)
ROE: -9.275653603605036%
Net margin: -17.450342219882256%
Asset turnover: 0.1984184518175458
Equity multiplier (leverage): 2.6789124256503705
EBIT margin: -13.520477352861404%
ROE archetype: Low Return
DuPont ROE decomposition for CRK (annual period ending 2025-12-31)
ROE: 15.867354096057223%
Net margin: 21.790794310786783%
Asset turnover: 0.2880466204038655
Equity multiplier (leverage): 2.5279510962726524
EBIT margin: 19.860751491818657%
Interest burden factor: 1.32834445213259
Tax burden factor: 0.8259745722732419
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CRL (quarterly period ending 2025-03-31)
ROE: 0.7982646581417258%
Net margin: 2.629429121857244%
Asset turnover: 0.12979695256071785
Equity multiplier (leverage): 2.338949997254596
EBIT margin: 7.587017663650922%
Interest burden factor: 0.48183315699955803
Tax burden factor: 0.7192728889877147
ROE archetype: Low Return
DuPont ROE decomposition for CRL (quarterly period ending 2025-06-30)
ROE: 1.586811632784089%
Net margin: 5.105243015690776%
Asset turnover: 0.1363192321476366
Equity multiplier (leverage): 2.2800891322390204
EBIT margin: 9.701637867139473%
Interest burden factor: 0.7132242794655163
Tax burden factor: 0.7378111960570164
ROE archetype: Low Return
DuPont ROE decomposition for CRL (quarterly period ending 2025-09-30)
ROE: 1.621977568327002%
Net margin: 5.528774386675848%
Asset turnover: 0.1333193847007869
Equity multiplier (leverage): 2.2005065979329976
EBIT margin: 13.315294192577614%
Interest burden factor: 0.651723854438374
Tax burden factor: 0.6371100917431193
ROE archetype: Low Return
DuPont ROE decomposition for CRL (quarterly period ending 2025-12-31)
ROE: -8.294492458808609%
Net margin: -27.789428369979895%
Asset turnover: 0.13573774574151795
Equity multiplier (leverage): 2.1989207162822155
EBIT margin: 9.307130061847042%
Interest burden factor: -3.1782804158471483
ROE archetype: Low Return
DuPont ROE decomposition for CRL (quarterly period ending 2026-03-31)
ROE: -0.4775218416561188%
Net margin: -1.4863982808310656%
Asset turnover: 0.1339766025617309
Equity multiplier (leverage): 2.3978890579525114
EBIT margin: 12.039906409728568%
Interest burden factor: -0.24973101912474874
ROE archetype: Low Return
DuPont ROE decomposition for CRTA.L (annual period ending 2022-12-31)
ROE: -178.7417738332428%
Net margin: -305.67888487351576%
Asset turnover: 0.37833509121450054
Equity multiplier (leverage): 1.5455533417859084
EBIT margin: -390.76923076923083%
ROE archetype: Low Return
DuPont ROE decomposition for CRTA.L (annual period ending 2023-12-31)
ROE: -225.32656555181342%
Net margin: -544.8693054518297%
Asset turnover: 0.2820175584395284
Equity multiplier (leverage): 1.4663711436799123
EBIT margin: -409.7684839432413%
ROE archetype: Low Return
DuPont ROE decomposition for CRTA.L (annual period ending 2024-12-31)
ROE: -102.35136212127533%
Net margin: -292.46590171032693%
Asset turnover: 0.24102117664776063
Equity multiplier (leverage): 1.451988527788847
EBIT margin: -329.1838060186187%
ROE archetype: Low Return
DuPont ROE decomposition for CRTA.L (annual period ending 2025-12-31)
ROE: -74.46430980002383%
Net margin: -59.8770112037739%
Asset turnover: 0.8748344163440971
Equity multiplier (leverage): 1.4215501786834388
EBIT margin: -37.37680060652009%
ROE archetype: Low Return
DuPont ROE decomposition for CRTX.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.231186440677966
ROE archetype: Standard Business
DuPont ROE decomposition for CRTX.L (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.27717613836922
ROE archetype: Standard Business
DuPont ROE decomposition for CRTX.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.2958593765600972
ROE archetype: Standard Business
DuPont ROE decomposition for CRVL (quarterly period ending 2025-03-31)
ROE: 8.20498964243898%
Net margin: 11.411404925836019%
Asset turnover: 0.4240369540053043
Equity multiplier (leverage): 1.6956460975132537
EBIT margin: 14.392218181189905%
Interest burden factor: 1
Tax burden factor: 0.7928871548619448
ROE archetype: Standard Business
DuPont ROE decomposition for CRVL (quarterly period ending 2025-06-30)
ROE: 8.196906333754189%
Net margin: 11.603631700261172%
Asset turnover: 0.41054062185156165
Equity multiplier (leverage): 1.7206791679395173
EBIT margin: 15.032529365901045%
Interest burden factor: 1
Tax burden factor: 0.7719014823002579
ROE archetype: Standard Business
DuPont ROE decomposition for CRVL (quarterly period ending 2025-09-30)
ROE: 7.913127437761322%
Net margin: 11.644821672237454%
Asset turnover: 0.3963894671288175
Equity multiplier (leverage): 1.7143252106523523
EBIT margin: 14.980617001122503%
Interest burden factor: 1
Tax burden factor: 0.7773259052924791
ROE archetype: Standard Business
DuPont ROE decomposition for CRVL (quarterly period ending 2025-12-31)
ROE: 6.546792886652521%
Net margin: 10.259522546419097%
Asset turnover: 0.3750598901999736
Equity multiplier (leverage): 1.7013780655085518
EBIT margin: 13.679363395225463%
Interest burden factor: 1
Tax burden factor: 0.75
ROE archetype: Standard Business
DuPont ROE decomposition for CRVL (quarterly period ending 2026-03-31)
ROE: 8.059972491827423%
Net margin: 12.484107697507122%
Asset turnover: 0.3860127305242935
Equity multiplier (leverage): 1.6725319597429973
EBIT margin: 15.979207235624507%
Interest burden factor: 1
Tax burden factor: 0.7812720314231041
ROE archetype: Standard Business
DuPont ROE decomposition for CRW.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.7196150936287482
ROE archetype: Standard Business
DuPont ROE decomposition for CRW.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.6294589896377172
ROE archetype: Standard Business
DuPont ROE decomposition for CRWS (quarterly period ending 2024-12-31)
ROE: 1.7483749706319995%
Net margin: 3.8242473555736374%
Asset turnover: 0.236487376064654
Equity multiplier (leverage): 1.9332171665752995
EBIT margin: 7.284484604513726%
Interest burden factor: 0.7495590828924162
Tax burden factor: 0.7003921568627451
ROE archetype: Low Return
DuPont ROE decomposition for CRWS (quarterly period ending 2025-03-31)
ROE: -23.787419372622526%
Net margin: -46.44164119343867%
Asset turnover: 0.258228411017538
Equity multiplier (leverage): 1.9835161806053256
EBIT margin: -1.4552029965126791%
ROE archetype: Low Return
DuPont ROE decomposition for CRWS (quarterly period ending 2025-06-30)
ROE: -2.8494734668593846%
Net margin: -7.132704483783435%
Asset turnover: 0.1969499354231217
Equity multiplier (leverage): 2.028404398100351
EBIT margin: -7.746478873239436%
ROE archetype: Low Return
DuPont ROE decomposition for CRWS (quarterly period ending 2025-09-30)
ROE: 3.035709600398814%
Net margin: 4.882886684954632%
Asset turnover: 0.3087537787970395
Equity multiplier (leverage): 2.013591163120195
EBIT margin: 7.86241823169445%
Interest burden factor: 0.8480944712828771
Tax burden factor: 0.7322784810126582
ROE archetype: Low Return
DuPont ROE decomposition for CRWS (quarterly period ending 2025-12-31)
ROE: 3.893960493063077%
Net margin: 7.288700101366027%
Asset turnover: 0.2698070574139312
Equity multiplier (leverage): 1.9801046985404096
EBIT margin: -0.5116570932084761%
Tax burden factor: 0.7163187855787476
ROE archetype: Low Return
DuPont ROE decomposition for CRWS (quarterly period ending 2026-03-31)
ROE: 0.717838281290058%
Net margin: 1.2513407222023596%
Asset turnover: 0.3049394577430719
Equity multiplier (leverage): 1.8812105829872328
EBIT margin: 2.4177690382552735%
Interest burden factor: 0.6155268022181146
Tax burden factor: 0.8408408408408409
ROE archetype: Low Return
DuPont ROE decomposition for CRWV (quarterly period ending 2025-03-31)
ROE: -10.26298658774267%
Net margin: -32.07739307535641%
Asset turnover: 0.044921445337897326
Equity multiplier (leverage): 7.122311667679933
EBIT margin: -2.74949083503055%
ROE archetype: Low Return
DuPont ROE decomposition for CRWV (quarterly period ending 2025-06-30)
ROE: -8.432664430410759%
Net margin: -23.953815506090102%
Asset turnover: 0.0504259450374213
Equity multiplier (leverage): 6.98129632016311
EBIT margin: 1.5838712124460335%
Interest burden factor: -12.63647248685512
ROE archetype: Low Return
DuPont ROE decomposition for CRWV (quarterly period ending 2025-09-30)
ROE: -2.8608020449887124%
Net margin: -8.069607731065835%
Asset turnover: 0.04614143923552971
Equity multiplier (leverage): 7.683237301300719
EBIT margin: 3.7994366428368345%
Interest burden factor: -4.567097396335583
ROE archetype: Low Return
DuPont ROE decomposition for CRWV (quarterly period ending 2025-12-31)
ROE: -12.52530495573695%
Net margin: -28.737505598306257%
Asset turnover: 0.03824002525747363
Equity multiplier (leverage): 11.39780097473816
EBIT margin: -5.699393856113351%
ROE archetype: Low Return
DuPont ROE decomposition for CRWV (quarterly period ending 2026-03-31)
ROE: -18.28514949345194%
Net margin: -35.611164581328204%
Asset turnover: 0.03962812872467223
Equity multiplier (leverage): 12.957128737336298
EBIT margin: -6.9297401347449465%
ROE archetype: Low Return
DuPont ROE decomposition for CS1.DE (quarterly period ending 2025-03-31)
ROE: -1.4484323192368098%
Net margin: -11.33879781420765%
Asset turnover: 0.07861387556382902
Equity multiplier (leverage): 1.6249200162875923
EBIT margin: -10.018214936247723%
ROE archetype: Low Return
DuPont ROE decomposition for CS1.DE (quarterly period ending 2025-06-30)
ROE: 5.5112730585288086%
Net margin: 26.26153011394465%
Asset turnover: 0.13234713295752396
Equity multiplier (leverage): 1.5856866317467546
EBIT margin: 35.64839934888768%
Interest burden factor: 0.9345509893455098
Tax burden factor: 0.7882736156351792
ROE archetype: Standard Business
DuPont ROE decomposition for CS1.DE (quarterly period ending 2025-09-30)
ROE: 3.031562612575166%
Net margin: 18.436130771823393%
Asset turnover: 0.10716220608950049
Equity multiplier (leverage): 1.5344583922188046
EBIT margin: 26.25547691270644%
Interest burden factor: 0.8806161745827985
Tax burden factor: 0.7973760932944607
ROE archetype: Low Return
DuPont ROE decomposition for CS1.DE (quarterly period ending 2025-12-31)
ROE: 3.0113265083859724%
Net margin: 16.556886227544908%
Asset turnover: 0.11951407152952964
Equity multiplier (leverage): 1.5218089740797212
EBIT margin: 26.88622754491018%
Interest burden factor: 0.765033407572383
Tax burden factor: 0.8049490538573508
ROE archetype: Low Return
DuPont ROE decomposition for CS1.DE (quarterly period ending 2026-03-31)
ROE: 6.080159479592908%
Net margin: 26.35288767621646%
Asset turnover: 0.15215887074453363
Equity multiplier (leverage): 1.5163151820375615
EBIT margin: 36.402910413824465%
Interest burden factor: 0.9300437226733291
Tax burden factor: 0.7783747481531229
ROE archetype: Standard Business
DuPont ROE decomposition for CSG.V (annual period ending 2022-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CSG.V (annual period ending 2023-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CSG.V (annual period ending 2024-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CSG.V (annual period ending 2025-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CSLFINANCE.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 2.165648804547536
ROE archetype: Standard Business
DuPont ROE decomposition for CSLFINANCE.NS (quarterly period ending 2024-12-31)
Net margin: 31.980385465263705%
EBIT margin: 46.68442295556416%
Interest burden factor: 0.9210868073706221
Tax burden factor: 0.7437228707862428
ROE archetype: Standard Business
DuPont ROE decomposition for CSLFINANCE.NS (quarterly period ending 2025-03-31)
ROE: 3.5034460654888133%
Net margin: 34.18241622053939%
Asset turnover: 0.044587547038365025
Equity multiplier (leverage): 2.298683071455988
EBIT margin: 44.682679213471%
Interest burden factor: 1.0060591401100563
Tax burden factor: 0.7603963808012566
ROE archetype: Low Return
DuPont ROE decomposition for CSLFINANCE.NS (quarterly period ending 2025-06-30)
Net margin: 36.43933074419495%
EBIT margin: 49.42479419084867%
Interest burden factor: 0.9536728009711591
Tax burden factor: 0.7730830045259371
ROE archetype: Standard Business
DuPont ROE decomposition for CSLFINANCE.NS (quarterly period ending 2025-09-30)
ROE: 4.210732383928902%
Net margin: 39.64668653116013%
Asset turnover: 0.044355372791043526
Equity multiplier (leverage): 2.394443036422915
EBIT margin: 46.289511482606684%
Interest burden factor: 1.0105591258514717
Tax burden factor: 0.847544619649974
ROE archetype: Low Return
DuPont ROE decomposition for CSLFINANCE.NS (quarterly period ending 2025-12-31)
Net margin: 33.093839276392586%
EBIT margin: 44.35607103197578%
Interest burden factor: 0.9091061468452661
Tax burden factor: 0.8206906561743625
ROE archetype: Standard Business
DuPont ROE decomposition for CSLFINANCE.NS (quarterly period ending 2026-03-31)
ROE: 3.123737068222127%
Net margin: 28.440685463848215%
Asset turnover: 0.045892083413776055
Equity multiplier (leverage): 2.3932972268914052
EBIT margin: 47.949511565261595%
Interest burden factor: 0.9220674085908838
Tax burden factor: 0.6432698551531295
ROE archetype: Low Return
DuPont ROE decomposition for CSNA3.SA (quarterly period ending 2025-03-31)
ROE: -3.8077714586820126%
Net margin: -5.676265666901578%
Asset turnover: 0.10934059683792437
Equity multiplier (leverage): 6.1351716863072205
EBIT margin: 7.418688332725654%
Interest burden factor: -1.1897014716949887
ROE archetype: Low Return
DuPont ROE decomposition for CSNA3.SA (quarterly period ending 2025-06-30)
ROE: -0.8066669222847986%
Net margin: -1.0502057289617095%
Asset turnover: 0.126683180742938
Equity multiplier (leverage): 6.063186216461277
EBIT margin: 8.713471599800961%
Interest burden factor: -0.23804408220320417
ROE archetype: Low Return
DuPont ROE decomposition for CSNA3.SA (quarterly period ending 2025-09-30)
ROE: 0.4534154238601364%
Net margin: 0.5700756451405523%
Asset turnover: 0.1347947567447981
Equity multiplier (leverage): 5.900527010459274
EBIT margin: 11.68476080211235%
Interest burden factor: 0.1790955609070815
Tax burden factor: 0.27241300660023665
ROE archetype: Low Return
DuPont ROE decomposition for CSNA3.SA (quarterly period ending 2025-12-31)
ROE: -4.291198924040741%
Net margin: -5.591666574275318%
Asset turnover: 0.12618328219842737
Equity multiplier (leverage): 6.081847981039767
EBIT margin: 9.398859500514535%
Interest burden factor: -0.6103609102937635
ROE archetype: Low Return
DuPont ROE decomposition for CSNA3.SA (quarterly period ending 2026-03-31)
ROE: -3.5809227246727366%
Net margin: -5.234203451375604%
Asset turnover: 0.10838645020059516
Equity multiplier (leverage): 6.312034397084476
EBIT margin: 2.5516108796002026%
Interest burden factor: -3.742171070381828
ROE archetype: Low Return
DuPont ROE decomposition for CSQ (quarterly period ending 2024-10-31)
Equity multiplier (leverage): 1.4803502015264784
ROE archetype: Standard Business
DuPont ROE decomposition for CSQ (quarterly period ending 2025-04-30)
Equity multiplier (leverage): 1.4930739003779772
ROE archetype: Standard Business
DuPont ROE decomposition for CSQ (quarterly period ending 2025-10-31)
Equity multiplier (leverage): 1.4608992638583755
ROE archetype: Standard Business
DuPont ROE decomposition for CSX (quarterly period ending 2025-03-31)
ROE: 5.305954825462012%
Net margin: 18.872334209757522%
Asset turnover: 0.0792379453228084
Equity multiplier (leverage): 3.5481724845995894
EBIT margin: 30.411919368974583%
Interest burden factor: 0.8242074927953891
Tax burden factor: 0.752913752913753
ROE archetype: Standard Business
DuPont ROE decomposition for CSX (quarterly period ending 2025-06-30)
ROE: 6.753014011078527%
Net margin: 23.195299384443203%
Asset turnover: 0.08299275496934795
Equity multiplier (leverage): 3.5079830563701533
EBIT margin: 35.898153329602685%
Interest burden factor: 0.8519095869056897
Tax burden factor: 0.7584629460201281
ROE archetype: Standard Business
DuPont ROE decomposition for CSX (quarterly period ending 2025-09-30)
ROE: 5.522180226775412%
Net margin: 19.347644270978535%
Asset turnover: 0.08321733481811433
Equity multiplier (leverage): 3.4297990849413167
EBIT margin: 34.875940897686085%
Interest burden factor: 0.7178257394084733
Tax burden factor: 0.7728285077951003
ROE archetype: Standard Business
DuPont ROE decomposition for CSX (quarterly period ending 2025-12-31)
ROE: 5.555984258044602%
Net margin: 20.524515393386544%
Asset turnover: 0.08067984498798311
Equity multiplier (leverage): 3.3552357434987266
EBIT margin: 32.58266818700114%
Interest burden factor: 0.8048993875765529
Tax burden factor: 0.782608695652174
ROE archetype: Standard Business
DuPont ROE decomposition for CSX (quarterly period ending 2026-03-31)
ROE: 6.0356755543921325%
Net margin: 23.176335439402642%
Asset turnover: 0.07921377710034806
Equity multiplier (leverage): 3.287610784936988
EBIT margin: 35.98506605399196%
Interest burden factor: 0.8483639265762171
Tax burden factor: 0.7591721542803387
ROE archetype: Standard Business
DuPont ROE decomposition for CSX (quarterly period ending 2026-06-30)
ROE: 7.242762658570964%
Net margin: 25.46378653113088%
Asset turnover: 0.0884687155736415
Equity multiplier (leverage): 3.2150782464129533
EBIT margin: 38.27191867852605%
Interest burden factor: 0.8764940239043825
Tax burden factor: 0.759090909090909
ROE archetype: Standard Business
DuPont ROE decomposition for CTEC.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 2.0811130846654824
ROE archetype: Standard Business
DuPont ROE decomposition for CTEC.L (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 2.081765743326634
ROE archetype: Standard Business
DuPont ROE decomposition for CTEC.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 2.267185312371857
ROE archetype: Standard Business
DuPont ROE decomposition for CTEV (quarterly period ending 2025-03-31)
ROE: -481.0725126475548%
Net margin: -30.82998314096745%
Asset turnover: 0.04549688427077933
Equity multiplier (leverage): 342.9695784148398
EBIT margin: 5.796481217308607%
Interest burden factor: -6.70206577671713
ROE archetype: Low Return
DuPont ROE decomposition for CTEV (quarterly period ending 2025-06-30)
Net margin: -25.930372148859544%
Asset turnover: 0.04756951801525407
EBIT margin: 6.862607111810242%
Interest burden factor: -5.00253347810351
ROE archetype: Standard Business
DuPont ROE decomposition for CTEV (quarterly period ending 2025-09-30)
Net margin: -28.359604649555415%
Asset turnover: 0.04888732485208871
EBIT margin: 4.092958582527982%
Interest burden factor: -9.273964438263633
ROE archetype: Standard Business
DuPont ROE decomposition for CTEV (quarterly period ending 2025-12-31)
Net margin: -32.67843961160638%
Asset turnover: 0.04991598641084371
EBIT margin: 3.5168766274325303%
Interest burden factor: -12.330411717218315
ROE archetype: Standard Business
DuPont ROE decomposition for CTEV (quarterly period ending 2026-03-31)
Net margin: -30.064002484898523%
Asset turnover: 0.050305121725388494
EBIT margin: 2.7288926670971643%
Interest burden factor: -13.886625730118316
ROE archetype: Standard Business
DuPont ROE decomposition for CTNT (quarterly period ending 2025-03-31)
ROE: -6.346063130916062%
Net margin: -157.13017326005266%
Asset turnover: 0.0330707860352215
Equity multiplier (leverage): 1.2212379212434263
EBIT margin: -200.17715751804403%
ROE archetype: Low Return
DuPont ROE decomposition for CTNT (quarterly period ending 2025-06-30)
ROE: -4.407362137074631%
Net margin: -144.73040669140363%
Asset turnover: 0.02493526267821181
Equity multiplier (leverage): 1.221251207981215
EBIT margin: -220.50033039087782%
ROE archetype: Low Return
DuPont ROE decomposition for CTNT (quarterly period ending 2025-09-30)
ROE: -12.219546580602044%
Net margin: -363.2282039592745%
Asset turnover: 0.027119676573495347
Equity multiplier (leverage): 1.2404835860114471
EBIT margin: -230.19934518629034%
ROE archetype: Low Return
DuPont ROE decomposition for CTNT (quarterly period ending 2025-12-31)
ROE: -10.963038105168904%
Net margin: -1153.066597608874%
Asset turnover: 0.007517897350962487
Equity multiplier (leverage): 1.26467851469575
EBIT margin: -1370.6612283654883%
ROE archetype: Low Return
DuPont ROE decomposition for CTNT (quarterly period ending 2026-03-31)
ROE: -2.11596435041364%
Net margin: -664.7950377562028%
Asset turnover: 0.0029497159816486936
Equity multiplier (leverage): 1.0790470361159799
EBIT margin: -824.5080906148868%
ROE archetype: Low Return
DuPont ROE decomposition for CTOS (annual period ending 2022-12-31)
ROE: 4.379009120450045%
Net margin: 2.4731642135267875%
Asset turnover: 0.5353888691489926
Equity multiplier (leverage): 3.307147447838522
EBIT margin: 8.233879139474892%
Interest burden factor: 0.3607924277751185
Tax burden factor: 0.8325130531541556
ROE archetype: Low Return
DuPont ROE decomposition for CTOS (annual period ending 2023-12-31)
ROE: 5.617047859879511%
Net margin: 2.718996300466463%
Asset turnover: 0.5915310301650378
Equity multiplier (leverage): 3.492383889200873
EBIT margin: 9.923918288563616%
Interest burden factor: 0.31376998341356416
Tax burden factor: 0.8732006336524554
ROE archetype: Standard Business
DuPont ROE decomposition for CTOS (annual period ending 2024-12-31)
ROE: -3.222356666696654%
Net margin: -1.5899305324366915%
Asset turnover: 0.524699247310388
Equity multiplier (leverage): 3.8626469767985823
EBIT margin: 6.70156690414364%
Interest burden factor: -0.24165224662819484
ROE archetype: Low Return
DuPont ROE decomposition for CTOS (annual period ending 2025-12-31)
ROE: -3.7178851684494605%
Net margin: -1.5973604354417303%
Asset turnover: 0.5599421380325347
Equity multiplier (leverage): 4.156711637607968
EBIT margin: 7.2831857906322%
Interest burden factor: -0.19868344846096256
ROE archetype: Low Return
DuPont ROE decomposition for CTP2.DE (annual period ending 2022-12-31)
ROE: 6.5457470928106485%
Net margin: 4.422410172366936%
Asset turnover: 0.4719735691380818
Equity multiplier (leverage): 3.136046710061191
EBIT margin: 18.631770528795077%
Interest burden factor: 0.41036067892503536
Tax burden factor: 0.5784144765187419
ROE archetype: Standard Business
DuPont ROE decomposition for CTP2.DE (annual period ending 2023-12-31)
ROE: 18.595208603969667%
Net margin: 12.6575198236436%
Asset turnover: 0.46571637622920364
Equity multiplier (leverage): 3.154502885109211
EBIT margin: 19.176290593228703%
Interest burden factor: 0.8783940290824862
Tax burden factor: 0.7514405703682
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTP2.DE (annual period ending 2024-12-31)
ROE: 19.078478387661203%
Net margin: 13.08645367773638%
Asset turnover: 0.46601082441028807
Equity multiplier (leverage): 3.128425071137792
EBIT margin: 18.82955766946036%
Interest burden factor: 0.801485106017684
Tax burden factor: 0.867134365126118
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTP2.DE (annual period ending 2025-12-31)
ROE: 21.77838279335693%
Net margin: 16.165617143734792%
Asset turnover: 0.4591587144283482
Equity multiplier (leverage): 2.9340702423087395
EBIT margin: 16.708836201670074%
Interest burden factor: 1.2465408805031446
Tax burden factor: 0.7761390980361716
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTQ.AX (annual period ending 2021-06-30)
Equity multiplier (leverage): 1.2718717589555273
ROE archetype: Standard Business
DuPont ROE decomposition for CTQ.AX (annual period ending 2022-06-30)
ROE: -62.58036734289851%
Net margin: -118.55337135104693%
Asset turnover: 0.4148281545341757
Equity multiplier (leverage): 1.2724946789181024
EBIT margin: -110.90141453172681%
ROE archetype: Low Return
DuPont ROE decomposition for CTQ.AX (annual period ending 2023-06-30)
ROE: -81.5312989256663%
Net margin: -74.62411174424028%
Asset turnover: 0.6938576751571423
Equity multiplier (leverage): 1.574616471138197
EBIT margin: -86.24346029391742%
ROE archetype: Low Return
DuPont ROE decomposition for CTQ.AX (annual period ending 2024-06-30)
ROE: -70.9128781996317%
Net margin: -35.31392097193824%
Asset turnover: 0.9983318917212269
Equity multiplier (leverage): 2.011426776032681
EBIT margin: -26.684299014603802%
ROE archetype: Low Return
DuPont ROE decomposition for CU6.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.1212612203729933
ROE archetype: Standard Business
DuPont ROE decomposition for CUB (quarterly period ending 2025-03-31)
ROE: 0.9576190823190748%
Asset turnover: 0
Equity multiplier (leverage): 1.0440421075950803
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CUB (quarterly period ending 2025-06-30)
ROE: 0.9741963367166826%
Asset turnover: 0
Equity multiplier (leverage): 1.0439241187447705
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CUB (quarterly period ending 2025-09-30)
ROE: 1.0008883854157213%
Asset turnover: 0
Equity multiplier (leverage): 1.0434074594655713
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CUB (quarterly period ending 2025-12-31)
ROE: 0.9239085391183702%
Asset turnover: 0
Equity multiplier (leverage): 1.0428907444044468
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CUB (quarterly period ending 2026-03-31)
ROE: 0.8150724858894206%
Asset turnover: 0
Equity multiplier (leverage): 1.0427940507335323
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CUB.NS (annual period ending 2023-03-31)
ROE: 12.571450647857551%
Net margin: 31.5328049922954%
Asset turnover: 0.04464372331182237
Equity multiplier (leverage): 8.93022460329735
Tax burden factor: 0.796174795399835
ROE archetype: Standard Business
DuPont ROE decomposition for CUB.NS (annual period ending 2024-03-31)
ROE: 12.715858291722332%
Net margin: 35.45192234530525%
Asset turnover: 0.04138311837412335
Equity multiplier (leverage): 8.667277004677862
Tax burden factor: 0.8253070594067313
ROE archetype: Standard Business
DuPont ROE decomposition for CUB.NS (annual period ending 2025-03-31)
ROE: 12.42629281671227%
Net margin: 34.96334768769823%
Asset turnover: 0.04277122757313363
Equity multiplier (leverage): 8.309537635314886
Tax burden factor: 0.7931705771663282
ROE archetype: Standard Business
DuPont ROE decomposition for CUB.NS (annual period ending 2026-03-31)
ROE: 12.626213939034619%
Net margin: 34.31461826267612%
Asset turnover: 0.04232015017254863
Equity multiplier (leverage): 8.694543241577016
Tax burden factor: 0.7935653419545234
ROE archetype: Standard Business
DuPont ROE decomposition for CUCU.V (quarterly period ending 2024-11-30)
ROE: -231.46827706635617%
Asset turnover: 0
Equity multiplier (leverage): 3.578240201785021
ROE archetype: Low Return
DuPont ROE decomposition for CUCU.V (quarterly period ending 2025-02-28)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CUCU.V (quarterly period ending 2025-05-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CUCU.V (quarterly period ending 2025-11-30)
Asset turnover: 0
Interest burden factor: -10.478420569329659
ROE archetype: Standard Business
DuPont ROE decomposition for CUCU.V (quarterly period ending 2026-02-28)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CUCU.V (quarterly period ending 2026-05-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CUPID.NS (annual period ending 2023-03-31)
ROE: 18.89789221617081%
Net margin: 20.309450516661855%
Asset turnover: 0.8235325580693352
Equity multiplier (leverage): 1.1298854618802634
EBIT margin: 24.67533803748877%
Interest burden factor: 1.1028585873590446
Tax burden factor: 0.7463030789952504
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CUPID.NS (annual period ending 2024-03-31)
ROE: 16.922234017357756%
Net margin: 23.786582760176568%
Asset turnover: 0.6548369770724303
Equity multiplier (leverage): 1.0864067290903714
EBIT margin: 28.472840605520926%
Interest burden factor: 1.1021890007063997
Tax burden factor: 0.7579580767489892
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CUPID.NS (annual period ending 2025-03-31)
ROE: 12.55658423881231%
Net margin: 22.2792122767221%
Asset turnover: 0.5243745945897343
Equity multiplier (leverage): 1.0748058972996375
EBIT margin: 20.297316987183503%
Interest burden factor: 1.4727395241329506
Tax burden factor: 0.7453070941351893
ROE archetype: Standard Business
DuPont ROE decomposition for CUPID.NS (annual period ending 2026-03-31)
ROE: 26.134426300552505%
Net margin: 30.257376950189652%
Asset turnover: 0.7426477643173707
Equity multiplier (leverage): 1.163051155746825
EBIT margin: 31.193110149932014%
Interest burden factor: 1.2767965728778774
Tax burden factor: 0.759715327770353
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CURA.TO (annual period ending 2022-12-31)
ROE: -26.420205908262172%
Net margin: -29.01781373978768%
Asset turnover: 0.3735239679490183
Equity multiplier (leverage): 2.437547204561906
EBIT margin: 5.095419548070439%
Interest burden factor: -1.3308303071336247
ROE archetype: Low Return
DuPont ROE decomposition for CURA.TO (annual period ending 2023-12-31)
ROE: -21.865083530642156%
Net margin: -20.88150289017341%
Asset turnover: 0.4136396475208013
Equity multiplier (leverage): 2.5314376134768732
EBIT margin: 3.1844631643982915%
Interest burden factor: -2.9001235920994333
ROE archetype: Low Return
DuPont ROE decomposition for CURA.TO (annual period ending 2024-12-31)
ROE: -22.004956841295616%
Net margin: -17.849747320503127%
Asset turnover: 0.44136166941546245
Equity multiplier (leverage): 2.793147270850031
EBIT margin: 1.8543819638626724%
Interest burden factor: -4.581416966414744
ROE archetype: Low Return
DuPont ROE decomposition for CURA.TO (annual period ending 2025-12-31)
ROE: -29.4978278581689%
Net margin: -21.326357209603078%
Asset turnover: 0.437663491585797
Equity multiplier (leverage): 3.160334388773577
EBIT margin: 2.0068841251128626%
Interest burden factor: -3.0732416502946953
ROE archetype: Low Return
DuPont ROE decomposition for CVC.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.945806551658458
ROE archetype: Standard Business
DuPont ROE decomposition for CVCB3.SA (quarterly period ending 2025-03-31)
ROE: -1.4317437267322375%
Net margin: -1.978495768350455%
Asset turnover: 0.10065753960440466
Equity multiplier (leverage): 7.189254410883867
EBIT margin: 9.394794272635334%
Interest burden factor: -0.13453257790368273
ROE archetype: Low Return
DuPont ROE decomposition for CVCB3.SA (quarterly period ending 2025-06-30)
ROE: -9.65015939514009%
Net margin: -13.334175681224927%
Asset turnover: 0.09519174477346194
Equity multiplier (leverage): 7.6027205383679455
EBIT margin: 8.98794772465562%
Interest burden factor: -1.3953480941883125
ROE archetype: Low Return
DuPont ROE decomposition for CVCB3.SA (quarterly period ending 2025-09-30)
ROE: 8.479788676945796%
Net margin: 10.443836039023637%
Asset turnover: 0.10761035870308369
Equity multiplier (leverage): 7.545202592467263
EBIT margin: 23.831154642090514%
Interest burden factor: 0.3009967422493582
Tax burden factor: 1.455972476077841
ROE archetype: Standard Business
DuPont ROE decomposition for CVCB3.SA (quarterly period ending 2025-12-31)
ROE: -5.552855139411051%
Net margin: -7.374475733972438%
Asset turnover: 0.10120662683699297
Equity multiplier (leverage): 7.440056656424283
EBIT margin: -1.423074362559084%
Tax burden factor: -1.398989643849457
ROE archetype: Low Return
DuPont ROE decomposition for CVCB3.SA (quarterly period ending 2026-03-31)
ROE: -16.793442721674232%
Net margin: -19.14388420651391%
Asset turnover: 0.10331583712487119
Equity multiplier (leverage): 8.490685988515411
EBIT margin: 5.121818220321036%
Interest burden factor: -2.779575171843506
ROE archetype: Low Return
DuPont ROE decomposition for CVR (quarterly period ending 2025-03-31)
ROE: 1.965361545424561%
Net margin: 5.534670184186755%
Asset turnover: 0.30101025476363585
Equity multiplier (leverage): 1.179694126145765
EBIT margin: 0.9685003453803566%
Interest burden factor: 6.004802348448143
Tax burden factor: 0.9516850546180298
ROE archetype: Low Return
DuPont ROE decomposition for CVR (quarterly period ending 2025-06-30)
ROE: -1.9560720243369472%
Net margin: -5.412110614892115%
Asset turnover: 0.3059259918004064
Equity multiplier (leverage): 1.181413150857734
EBIT margin: -5.719739597156895%
ROE archetype: Low Return
DuPont ROE decomposition for CVR (quarterly period ending 2025-09-30)
ROE: 0.3378630407673669%
Net margin: 0.9180624008530105%
Asset turnover: 0.30881069631985275
Equity multiplier (leverage): 1.1917252755274796
EBIT margin: 0.8772759312004809%
Interest burden factor: 1.0419854421558
Tax burden factor: 1.0043251437998841
ROE archetype: Low Return
DuPont ROE decomposition for CVR (quarterly period ending 2025-12-31)
ROE: -5.954991318943975%
Net margin: -19.32472729647862%
Asset turnover: 0.25296016629223994
Equity multiplier (leverage): 1.2181916563438422
EBIT margin: -20.940443144579515%
ROE archetype: Low Return
DuPont ROE decomposition for CVR (quarterly period ending 2026-03-31)
ROE: -1.942369547053629%
Net margin: -5.283720379005117%
Asset turnover: 0.29049813342215663
Equity multiplier (leverage): 1.2654607752174647
EBIT margin: -5.569438125892412%
ROE archetype: Low Return
DuPont ROE decomposition for CVS (annual period ending 2022-12-31)
ROE: 6.029065473951149%
Net margin: 1.3418427311941996%
Asset turnover: 1.4126251232066587
Equity multiplier (leverage): 3.1806908275160586
EBIT margin: 5.051679706760692%
Interest burden factor: 0.35825659914057706
Tax burden factor: 0.7414324880054832
ROE archetype: Standard Business
DuPont ROE decomposition for CVS (annual period ending 2023-12-31)
ROE: 11.277248071156633%
Net margin: 2.338893609409239%
Asset turnover: 1.4969613161423674
Equity multiplier (leverage): 3.2209359522927126
EBIT margin: 4.080486114216717%
Interest burden factor: 0.7653263922186451
Tax burden factor: 0.7489483576479012
ROE archetype: Standard Business
DuPont ROE decomposition for CVS (annual period ending 2024-12-31)
ROE: 6.056469291049185%
Net margin: 1.2376310657736267%
Asset turnover: 1.482509946455165
Equity multiplier (leverage): 3.30088733706995
EBIT margin: 2.600527347783986%
Interest burden factor: 0.6341413099535843
Tax burden factor: 0.7504879635653872
ROE archetype: Standard Business
DuPont ROE decomposition for CVS (annual period ending 2025-12-31)
ROE: 2.3399862353750858%
Net margin: 0.4397277070736966%
Asset turnover: 1.5868361904122916
Equity multiplier (leverage): 3.35349277357192
EBIT margin: 2.5829028495250794%
Interest burden factor: 0.20568127106403467
Tax burden factor: 0.8277153558052435
ROE archetype: Low Return